{"id":{"repo_id":"rowan","oai_identifier":"oai:rdw.rowan.edu:etd-4577"},"canonical_url":"https://search.ndltd.org/etd/rowan/oai:rdw.rowan.edu:etd-4577","repository":{"repo_id":"rowan","name":"Rowan University","base_url":"https://rdw.rowan.edu/do/oai/"},"display":{"title":"Behavioral Effects of Novel Treatments for Pain Management Using Combinatorial Methods","abstract":"Pain, despite being an uncomfortable feeling to experience, is a necessary protective mechanism for the body1. Understanding that pain results from several different mechanisms within the body is important to discovering the optimal way to treat and manage a person’s pain. Modern medicine has seen numerous advancements in treating or managing acute and chronic pain, particularly with opioid drugs. However, these treatments come with potential side effects, including opioid use disorder (OUD) and fatal overdose. Finding new treatment methods, or improving existing methods, is crucial for patients with pain. This thesis explores two projects looking to develop safer analgesia using drug combination therapies. In one project, I investigated the potential synergistic and analgesic effects of CP-55,940, a cannabinoid-1 (CB1) receptor agonist, and DS-II-048, a GABAA positive allosteric modulator (PAM). The co-administration of CP-55,940 and DS-II-048 at a 1:7.83 ratio resulted in a non-synergistic interaction for both thermal nociception and mechanical antihyperalgesia. In a second project, using fiber photometry, I investigated the effects of the co-administration of the opioid morphine with MP-III-024, a GABAA PAM, on dopamine release in the nucleus accumbens. Our results indicated that MP-III-024 does not affect the dopamine release when co-administered with morphine.","abstract_html":"Pain, despite being an uncomfortable feeling to experience, is a necessary protective mechanism for the body1. Understanding that pain results from several different mechanisms within the body is important to discovering the optimal way to treat and manage a person’s pain. Modern medicine has seen numerous advancements in treating or managing acute and chronic pain, particularly with opioid drugs. However, these treatments come with potential side effects, including opioid use disorder (OUD) and fatal overdose. Finding new treatment methods, or improving existing methods, is crucial for patients with pain. This thesis explores two projects looking to develop safer analgesia using drug combination therapies. In one project, I investigated the potential synergistic and analgesic effects of CP-55,940, a cannabinoid-1 (CB1) receptor agonist, and DS-II-048, a GABAA positive allosteric modulator (PAM). The co-administration of CP-55,940 and DS-II-048 at a 1:7.83 ratio resulted in a non-synergistic interaction for both thermal nociception and mechanical antihyperalgesia. In a second project, using fiber photometry, I investigated the effects of the co-administration of the opioid morphine with MP-III-024, a GABAA PAM, on dopamine release in the nucleus accumbens. Our results indicated that MP-III-024 does not affect the dopamine release when co-administered with morphine.","abstract_has_math":false,"creators":["Nambiar, Rohit Rajeev"],"institution":null,"degree_name":"M.S. Pharmaceutical Sciences","degree_level":"Thesis","degree_discipline":"Chemistry and Biochemistry","degree_department":null,"school":null,"contributors":["Thomas M. Keck, Ph.D.","Daniel Manvich, Ph.D.","Subash Jonnalagadda, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T09:00:08Z","subjects":[],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://rdw.rowan.edu/etd/3571","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://rdw.rowan.edu/etd/3571","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://rdw.rowan.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Ardw.rowan.edu%3Aetd-4577","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Thomas M. Keck, Ph.D.","Daniel Manvich, Ph.D.","Subash Jonnalagadda, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Nambiar, Rohit Rajeev"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2026-08-10T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2026-08-10T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry and Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.S. Pharmaceutical Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://rdw.rowan.edu/etd/3571"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Pain, despite being an uncomfortable feeling to experience, is a necessary protective mechanism for the body1. Understanding that pain results from several different mechanisms within the body is important to discovering the optimal way to treat and manage a person’s pain. Modern medicine has seen numerous advancements in treating or managing acute and chronic pain, particularly with opioid drugs. However, these treatments come with potential side effects, including opioid use disorder (OUD) and fatal overdose. Finding new treatment methods, or improving existing methods, is crucial for patients with pain. This thesis explores two projects looking to develop safer analgesia using drug combination therapies. In one project, I investigated the potential synergistic and analgesic effects of CP-55,940, a cannabinoid-1 (CB1) receptor agonist, and DS-II-048, a GABAA positive allosteric modulator (PAM). The co-administration of CP-55,940 and DS-II-048 at a 1:7.83 ratio resulted in a non-synergistic interaction for both thermal nociception and mechanical antihyperalgesia. In a second project, using fiber photometry, I investigated the effects of the co-administration of the opioid morphine with MP-III-024, a GABAA PAM, on dopamine release in the nucleus accumbens. Our results indicated that MP-III-024 does not affect the dopamine release when co-administered with morphine."]},{"key":"dc:title","label":"Title","values":["Behavioral Effects of Novel Treatments for Pain Management Using Combinatorial Methods"]}]}],"canonical_facts":{"dc:contributor":["Thomas M. Keck, Ph.D.","Daniel Manvich, Ph.D.","Subash Jonnalagadda, Ph.D."],"dc:creator":["Nambiar, Rohit Rajeev"],"dc:date.available":["2026-08-10T07:00:00Z"],"dc:date.created":["2026-08-10T07:00:00Z"],"dc:description.abstract":["Pain, despite being an uncomfortable feeling to experience, is a necessary protective mechanism for the body1. Understanding that pain results from several different mechanisms within the body is important to discovering the optimal way to treat and manage a person’s pain. Modern medicine has seen numerous advancements in treating or managing acute and chronic pain, particularly with opioid drugs. However, these treatments come with potential side effects, including opioid use disorder (OUD) and fatal overdose. Finding new treatment methods, or improving existing methods, is crucial for patients with pain. This thesis explores two projects looking to develop safer analgesia using drug combination therapies. In one project, I investigated the potential synergistic and analgesic effects of CP-55,940, a cannabinoid-1 (CB1) receptor agonist, and DS-II-048, a GABAA positive allosteric modulator (PAM). The co-administration of CP-55,940 and DS-II-048 at a 1:7.83 ratio resulted in a non-synergistic interaction for both thermal nociception and mechanical antihyperalgesia. In a second project, using fiber photometry, I investigated the effects of the co-administration of the opioid morphine with MP-III-024, a GABAA PAM, on dopamine release in the nucleus accumbens. Our results indicated that MP-III-024 does not affect the dopamine release when co-administered with morphine."],"dc:identifier":["https://rdw.rowan.edu/etd/3571"],"dc:title":["Behavioral Effects of Novel Treatments for Pain Management Using Combinatorial Methods"],"thesis:degree_discipline":["Chemistry and Biochemistry"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["M.S. Pharmaceutical Sciences"]},"updated_at":"2026-11-19T09:00:08Z"}